GT Biopharma annual depreciation and amortization
2014
2015
2016
2017
2018
2019
2020
GT Biopharma Depreciation & Amortization Growth & History (GTBP)
GT Biopharma's depreciation and amortization was $0 for fiscal 2020.
View full GT Biopharma company overviewGT Biopharma annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2020 | 2020-12-31 | $0 | −$4,000 | — |
| 2019 | 2019-12-31 | $4,000 | −$3,000 | −42.86% |
| 2018 | 2018-12-31 | $7,000 | $5,000 | +250.00% |
| 2017 | 2017-12-31 | $2,000 | $1,000 | +100.00% |
| 2016 | 2016-12-31 | $1,000 | −$1,000 | −50.00% |
| 2015 | 2015-12-31 | $2,000 | −$20,000 | −90.91% |
| 2014 | 2014-12-31 | $22,000 | — | — |
GT Biopharma quarterly depreciation and amortization
Q1.14
Q2.14
Q3.14
Q1.15
Q2.15
Q3.15
Q1.16
Q2.16
Q3.16
Q1.17
Q2.17
Q3.17
Q1.18
Q2.18
Q3.18
Q1.19
Q2.19
Q3.19
Q1.20
Q2.20
Q3.20
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q3 2020 | 2020-09-30 | $0 | $0 | — |
| Q2 2020 | 2020-06-30 | $0 | −$9,000 | — |
| Q1 2020 | 2020-03-31 | $0 | −$1,000 | — |
| Q3 2019 | 2019-09-30 | $0 | −$3,000 | — |
| Q2 2019 | 2019-06-30 | $9,000 | $8,000 | +800.00% |
| Q1 2019 | 2019-03-31 | $1,000 | $0 | 0.00% |
| Q3 2018 | 2018-09-30 | $3,000 | $2,000 | +200.00% |
| Q2 2018 | 2018-06-30 | $1,000 | $1,000 | — |
| Q1 2018 | 2018-03-31 | $1,000 | $0 | 0.00% |
| Q3 2017 | 2017-09-30 | $1,000 | $0 | 0.00% |
| Q2 2017 | 2017-06-30 | $0 | $0 | — |
| Q1 2017 | 2017-03-31 | $1,000 | $1,000 | — |
| Q3 2016 | 2016-09-30 | $1,000 | $1,000 | — |
| Q2 2016 | 2016-06-30 | $0 | $0 | — |
| Q1 2016 | 2016-03-31 | $0 | −$1,000 | — |
| Q3 2015 | 2015-09-30 | $0 | $0 | — |
| Q2 2015 | 2015-06-30 | $0 | −$1,000 | — |
| Q1 2015 | 2015-03-31 | $1,000 | $0 | 0.00% |
| Q3 2014 | 2014-09-30 | $0 | — | — |
| Q2 2014 | 2014-06-30 | $1,000 | — | — |
| Q1 2014 | 2014-03-31 | $1,000 | — | — |
GT Biopharma depreciation and amortization trends
Over the last five fiscal years, GT Biopharma's depreciation and amortization decreased from $2,000 to $0, a change of −$2,000. The latest reported quarter, Q3 2020, shows $0.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review GT Biopharma source filings ↗